Company Search:
Advanced Search
Sponsored Links
Pfizer Inc. Company Snapshot
Pfizer Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pfizer Inc. with three other companies in this sector in the United States: Novartis AG (2015 sales of $50.36 billion of which 60% was Pharmaceuticals), Merck & Co. , Inc. ($39.50 billion of which 88% was Merck Pharmaceutical), and Sanofi S.A. ($38.45 billion of which 85% was Pharmaceuticals).

Sales Analysis. During the year ended December of 2015, sales at Pfizer Inc. were $48.85 billion. This is a decrease of 1.5% versus 2014, when the company's sales were $49.61 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pfizer Inc.
  Stock Performance Chart for Pfizer Inc.
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 32.18
(Figures in U.S. Dollars)
1 Week -1.5%   13 Weeks -6.1%  
4 Weeks -12.4%   52 Weeks -5.5%  
Pfizer Inc. Key Data:
  Ticker: PFE Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 48,851,000,000
(Year Ending Jan 2016).
Employees: 97,900
  Currency: U.S. Dollars Market Cap: 195,192,695,004
  Fiscal Yr Ends: December Shares Outstanding: 6,065,652,424
  Share Type: Common Closely Held Shares: 1,858,842
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.